Medicare Enrolled
Dr. John Naitoh, MD
Urology Physician · La Jolla, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Naitoh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naitoh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Naitoh
Dr. John Naitoh is an urology physician in La Jolla, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Naitoh performed 4,460 Medicare services across 2,442 unique beneficiaries.
Between the years covered by Open Payments, Dr. Naitoh received a total of $5,941 from 67 pharmaceutical and/or device companies across 280 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Naitoh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 20% volume in CA
$5,941 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,460
Medicare services
Top 20% in CA for urology physician
2,442
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~235 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
995 | $101 | $601 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
886 | $50 | $300 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
822 | $2 | $9 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
317 | $101 | $730 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
311 | $96 | $605 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
204 | $10 | $60 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
155 | $69 | $440 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
125 | $196 | $1,230 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
97 | $127 | $780 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
89 | $0 | $2 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
74 | $12 | $80 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 74 | $133 | $720 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
55 | $141 | $840 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
41 | $61 | $385 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
30 | $72 | $430 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
25 | $28 | $180 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
22 | $20 | $120 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $94 | $220 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
19 | $121 | $746 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $143 | $504 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $107 | $563 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
16 | $279 | $1,635 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $211 | $1,180 |
| Insertion of temporary bladder tube | 15 | $33 | $215 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
15 | $36 | $245 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
16.6% medium
83.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,941
Total received (2018-2024)
Avg $849/year across 7 years
Top 30% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
280
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,794 (97.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$147 (2.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$766
2023
$1,003
2022
$798
2021
$1,290
2020
$422
2019
$884
2018
$778
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Valencia Technologies Corporation
$152
ABBVIE INC.
$120
ACCORD HEALTHCARE, INC.
$99
Sumitomo Pharma America, Inc.
$78
Bayer Healthcare Pharmaceuticals Inc.
$65
PFIZER INC.
$35
Ferring Pharmaceuticals Inc.
$35
UROGEN PHARMA, INC.
$32
Teleflex LLC
$28
Myriad Genetic Laboratories, Inc.
$28
AstraZeneca Pharmaceuticals LP
$27
IMMUNITYBIO, INC.
$25
PROGENICS PHARMACEUTICALS, INC.
$24
Olympus America Inc.
$17
Top 3 companies account for 48.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$456
Coloplast Corp
$358
PFIZER INC.
$299
ABBVIE INC.
$298
Janssen Biotech, Inc.
$218
UROGEN PHARMA, INC.
$209
Teleflex LLC
$197
Antares Pharma, Inc.
$177
Myriad Genetic Laboratories, Inc.
$173
ACCORD HEALTHCARE, INC.
$166
COLOPLAST CORP
$162
UroGen Pharma, Inc.
$161
AbbVie Inc.
$158
Valencia Technologies Corporation
$152
Myovant Sciences Inc.
$152
Rochester Medical Corporation
$134
Bayer HealthCare Pharmaceuticals Inc.
$119
Blue Earth Diagnostics Limited
$116
Dendreon Pharmaceuticals LLC
$114
ConvaTec Inc.
$109
Bayer Healthcare Pharmaceuticals Inc.
$108
UROVANT SCIENCES INC
$93
Amgen Inc.
$85
AbbVie, Inc.
$85
DENTSPLY IH Inc.
$82
Sumitomo Pharma America, Inc.
$78
Bard Access Systems, Inc.
$71
West Therapeutics Development, LLC
$71
180 Medical, Inc.
$69
Axonics, Inc.
$67
Travere Therapeutics, Inc.
$67
Aytu BioScience, Inc
$67
Allergan, Inc.
$65
Mission Pharmacal Company
$62
Zyla Life Sciences
$55
Ferring Pharmaceuticals Inc.
$55
Avadel Specialty Pharmaceuticals, LLC
$51
AstraZeneca Pharmaceuticals LP
$50
Acerus Pharmaceuticals Corporation
$47
Photocure Inc
$44
Merck Sharp & Dohme Corporation
$43
C. R. Bard, Inc. & Subsidiaries
$43
Endo Pharmaceuticals Inc.
$40
Retrophin, Inc.
$37
Duchesnay USA Incorporated
$35
MEDIVATION FIELD SOLUTIONS LLC
$31
Zyla Life Sciences, Inc.
$30
AngioDynamics, Inc.
$28
Alnylam Pharmaceuticals Inc.
$26
IMMUNITYBIO, INC.
$25
PROGENICS PHARMACEUTICALS, INC.
$24
Progenics Pharmaceuticals, Inc.
$22
ABC Home Medical Supply, Inc.
$21
Richard Wolf Medical Instruments Corp.
$20
C. R. BARD, INC. & SUBSIDIARIES
$20
Supernus Pharmaceuticals, Inc.
$19
PRN Medical Services, LLC
$19
Allergan Inc.
$19
PROCEPT BioRobotics Corporation
$18
Medtronic, Inc.
$17
Telix Pharmaceuticals
$17
Olympus America Inc.
$17
Sagent Pharmaceuticals, Inc.
$15
RGH Enterprises, Inc.
$15
Boston Scientific Corporation
$14
Metuchen Pharmaceuticals
$14
Egalet US Inc
$12
Top 3 companies account for 18.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ANKTIVA · AQUABEAM ROBOTIC SYSTEM · AVYCAZ · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bard Urinary Drainage Bag · CAMCEVI · CONTINENCE CARE · Cysview · ERLEADA · Erleada · GEMTESA · GENTLECATH · GENTLECATH GLIDE · GREENLIGHT · GentleCath · Glydo · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · Lazanda · Ligation Solutions: Weck & Horizon brands · LoFric · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OXLUMO · Osphena · Otrexup · POSLUMA · PREMARIN · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · ROCHESTER MAGIC3 · SELF-CATH · SPEEDICATH · SPRIX · SpeediCath · Stendra · TLANDO · TOVIAZ · Thiola · Titan · UROLIFT · Uribel · UroLift System · Urocit-K · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · ZORVOLEX · eCoin Device Kit · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
137
Per 100K population
4.2
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL LA JOLLA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Naitoh is a clinical cardiology specialist, with above-average Medicare volume (top 20% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Naitoh experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Naitoh performed 995 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Naitoh receive payments from pharmaceutical companies?
Yes. Dr. Naitoh received a total of $5,941 from 67 companies across 280 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Naitoh's costs compare to other urology physicians in La Jolla?
Dr. Naitoh's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Naitoh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in La Jolla
Browse urology physicians in La Jolla ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology